聚合酶链反应早期识别通气和创伤患者肺炎致病菌
该诊断准确性研究纳入151例插管外科重症疑似肺炎患者,共238次支气管肺泡灌洗(BAL),同步行定量培养与Biofire FilmArray肺炎面板(BFPP)检测。以BAL定量培养≥10^5 CFU/mL为肺炎阳性标准,82次(34.5%)为阳性,并与BFPP报告的每毫升基因组拷贝数(GCN/mL)做相关分析,采用McNemar分析。作者结论认为,在高临床怀疑肺炎的通气患者中,BFPP cutoff 10^6 GCN/mL是启动针对已识别病原体抗生素的敏感且特异的检测;BFPP阴性结果因阴性预测值99.8%可能限制不必要的经验性抗生素覆盖。证据等级为诊断性试验/标准,Level III。
要点
- 插管创伤患者呼吸机相关肺炎发生率为20%~25%,早期有效抗生素治疗可降低并发症和死亡率。
- 研究纳入151例插管外科重症疑似肺炎患者,共238次BAL,其中82次(34.5%)定量培养≥10^5 CFU/mL判为肺炎阳性。
- 作者结论:对高临床怀疑肺炎的通气患者,BFPP cutoff 10^6 GCN/mL是启动针对已识别病原体抗生素的敏感且特异的检测。
- BFPP阴性预测值为99.8%,作者认为阴性结果可能限制不必要的、有潜在伤害的经验性抗生素覆盖。
适用人群与场景
- 插管的外科与创伤重症患者,临床怀疑发生肺炎时接受纤维支气管镜BAL检查。
诊断标准与关键阈值
- BAL定量培养≥10^5 CFU/mL视为符合肺炎诊断。
- BFPP检测以10^6 GCN/mL作为cutoff值。
处置流程与药物剂量
- 在高临床怀疑肺炎的通气患者中,BFPP cutoff 10^6 GCN/mL用于启动针对已识别病原体的抗生素。
- BFPP阴性结果(阴性预测值99.8%)可能限制不必要的、有潜在伤害的经验性抗生素覆盖。
研究设计与关键结果
- 诊断准确性研究,3年研究期间共151例插管外科重症疑似肺炎患者接受238次BAL定量培养与BFPP检测。
- 238次BAL中82次(34.5%)定量培养≥10^5 CFU/mL判为肺炎阳性,并与BFPP报告的GCN/mL做相关分析。
- 采用McNemar分析。
证据类型、等级与局限
- 证据类型:诊断准确性研究;证据等级:诊断性试验/标准,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对插管外科/创伤患者高临床怀疑肺炎时,作者认为BFPP cutoff 10^6 GCN/mL是启动目标抗生素的敏感且特异检测。
- 作者认为BFPP阴性结果(阴性预测值99.8%)可能限制不必要的、有潜在伤害的经验性抗生素覆盖。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Ventilator-associated pneumonia occurs in 20% to 25% of intubated trauma patients, and early effective antibiotic treatment decreases morbidity and mortality. We sought to determine the sensitivity and specificity of multiplex polymerase chain reaction amplification of bacterial DNA (Biofire FilmArray Pneumonia Panel [BFPP]) obtained during fiberoptic bronchoscopy in predicting the causative bacteria the day of bronchoalveolar lavage (BAL).
METHODS: This diagnostic accuracy study compared results of BAL with quantitative culture and BFPP testing on all intubated trauma and surgery patients suspected of developing pneumonia. Demographics, clinical data, BAL culture results, and BFPP results were recorded. McNemar analysis was performed.
RESULTS: Over a 3-year study period, 151 intubated surgical critical care patients suspected of developing pneumonia underwent 238 BALs with quantitative culture and BFPP testing. Bronchoalveolar lavages that had ≥10 5 colony-forming units/mL growth were considered consistent with the diagnosis of pneumonia. Of the 238 BALs, 82 (34.5%) were considered positive and then correlated to the genomic copy number per milliliter (GCN/mL) reported by BFPP testing.
CONCLUSION: In ventilated patients with high clinical suspicion for pneumonia, a BFPP cutoff value of 10 6 GCN/mL is a sensitive and specific test for initiating antibiotics targeted to the identified organism(s). In addition, a negative BFPP result may limit unnecessary and potentially harmful empiric antibiotic coverage, as its negative predictive value is 99.8%.
LEVEL OF EVIDENCE: Diagnostic Tests/Criteria; Level III.
参考来源
- Pollock A, Bailey J, Parmer H, et al. Polymerase chain reaction for early identification of bacteria causing pneumonia in ventilated surgical and trauma patients. J Trauma Acute Care Surg. 2025. PMID: 40013862. doi:10.1097/TA.0000000000004571
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。